在青少年中使用兰德鲁马布长期预防遗传性血管发作
Timothy Craig1, Raffi Tachdjian2, Jonathan A Bernstein3
1Allergy, Asthma, and Immunology Section, Departments of Medicine, Pediatrics, and Biomedical Sciences, Director ACARE International Hereditary Angioedema Resource Center, Penn State University, Hershey, Pennsylvania; Department of Allergy and Immunology, Vinmec International Hospital, Times City, Hanoi, Vietnam.
概括
兰德鲁马布有效地预防了青少年遗传性血管 (HAE) 发作,显著降低了发作率并改善了生活质量. 治疗耐受性良好,患者满意度高,不良反应最小.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 遗传性血管 (HAE) 是一种罕见的遗传性疾病,其特征是经常出现的发作.
- 一种单克隆抗体 - - 拉纳德鲁马布 - - 向血卡利克林,以防止HAE攻击.
- 之前的研究表明,lanadelumab在成人HAE患者的疗效和安全性.
研究的目的:
- 评估Lanadelumab在HAE青少年患者的长期疗效和安全性.
- 评估患者报告的结果,包括生活质量,在这个特定的年龄组.
主要方法:
- 该研究包括了来自遗传性血管水长期预防 (HELP) 开放式扩展 (OLE) 研究的青少年患者 (12-17岁).
- 患者每两周接受300毫克的lanadelumab,治疗启动策略因翻转和未使用lanadelumab的参与者而异.
- 结果包括每月的发作率,无发作日,以及血管质量生活问卷 (AE-QoL).
主要成果:
- 平均每月HAE发作率显著减少,从基线时的1.58降至治疗期间的0.11 (降低94.7%).
- 38.1%的患者完全摆脱了发作,平均有99.1%的天没有发作.
- 在AE-QoL得分中观察到临床上有意义的改善,平均从27.5降至7.5.5.
- 57.1%的患者报告了与治疗相关的不良事件,但没有发生与治疗相关的严重不良事件.
结论:
- 兰德鲁马布在预防青少年HAE发作方面表现出持续的有效性.
- 治疗导致了与健康相关的生活质量和高治疗满意度的显著改善.
- 在这个青少年群体中,lanadelumab耐受性很好,具有良好的安全性.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
01:25Antihypertensive Drugs: Direct Renin Inhibitors
517
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
517
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406